A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer
- Citation:
- Clin Cancer Res vol 16 (21) 5222-5232
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- 895
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Breast
- Pharmas:
- Grants:
- U01 CA114722-01, P30 ES010126, P30 CA42014-19, P50-CA58223-09A1, U01 CA114722, P30 CA91842, P50 CA058223, P30 CA091842, P30 CA042014
- Corr. Author:
- Torsten O. Nielsen
- Authors:
- Torsten O. Nielsen Joel S Parker Samuel Leung David Voduc Mark Ebbert Tammi Vickery Sherri R. Davies Jacqueline Snider Inge J. Stijleman Jerry Reed Maggie C.U. Cheang Elaine R. Mardis Charles M. Perou Philip S. Bernard Matthew J. Ellis
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-159905, CALGB-9344
- Phases:
- 3, N/A
- Keywords:
- Article